GSA Capital Partners LLP Invests $567,000 in HCA Healthcare, Inc. (NYSE:HCA)

GSA Capital Partners LLP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,394 shares of the company’s stock, valued at approximately $567,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Capital World Investors lifted its position in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP lifted its position in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares in the last quarter. TD Asset Management Inc lifted its position in HCA Healthcare by 2.7% during the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after buying an additional 19,812 shares in the last quarter. Epoch Investment Partners Inc. lifted its position in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the period. Finally, National Pension Service lifted its position in HCA Healthcare by 11.9% during the 3rd quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after purchasing an additional 58,353 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research reports. UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Barclays cut their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. KeyCorp lowered their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Royal Bank of Canada upped their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Price Performance

Shares of HCA opened at $335.11 on Wednesday. The stock has a market capitalization of $84.88 billion, a P/E ratio of 15.05, a P/E/G ratio of 1.32 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $245.03 and a twelve month high of $417.14. The company has a 50 day moving average of $383.10 and a 200-day moving average of $358.30. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.